Allergan joins TriNetX for real-time access to real-world data

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/alexsi)
(Image: Getty/alexsi)

Related tags: Real world data, Real world evidence, Patient recruitment, Health care

Allergan joined the TriNetX network to gain access to patient populations, protocol, and site identification through real-world data.

Gadi Lachman, CEO of TriNetX told us that the real-world data Allergan will have access to involves clinical data from the electronic medical records (EMR), genomics, and oncology among other things.

TriNetX says its platform provides industry members with access to patient populations​, cohort analysis, and site identification services​. The TriNetX platform includes real-time access to de-identified real-world data​ from more than 135 million patients.

“[Access to real-world data] is core to how protocols are designed and ultimately how a drug goes to market,”​ said Lachman. “There are also platform features that allow pharma and healthcare organizations to collaborate on study opportunities and placement.”

The TriNetX network has partnerships with household pharmaceutical and health care companies like Sanofi​, Pfizer​, Tufts​, and Boston Children’s Hospital. Allergan is the latest to join the other well-known companies in the network.

TriNetX tools

TriNetX recently released tools that enable health research on a wider spectrum. The company currently has a cloud-platform called TNX, which provides longitudinal clinical data and analytics. More tools will be released later this year and will build on the current and new tools available on the TriNetX platform.

TriNetX has said that it is working towards addressing the importance of real-world data to generate real-world evidence, and is aiming to provide access to it through tools on its platform.

To provide this network of data assets TriNetX is partnered with over 80 healthcare organizations in over 16 countries. 

Related news

Show more

Related products

show more

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Next generation ePRO from SQN Health

Next generation ePRO from SQN Health

Syne Qua Non Clinical | 16-May-2018 | Business Advice

In an era of rapid technology growth, healthcare requires low cost solutions for real-time data collection. We have come a long way from paper to EDC and...

Related suppliers

Follow us

Products

View more

Webinars